Compare OVV & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVV | ZBH |
|---|---|---|
| Founded | 2020 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 16.0B |
| IPO Year | 2019 | 2001 |
| Metric | OVV | ZBH |
|---|---|---|
| Price | $64.51 | $101.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 21 |
| Target Price | $58.35 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 3.2M | 2.2M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.96% | 1.20% |
| EPS Growth | ★ 13.54 | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $8,908,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $5.45 | $4.96 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | ★ N/A | $44.21 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $35.47 | $79.12 |
| 52 Week High | $67.44 | $106.88 |
| Indicator | OVV | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 56.37 |
| Support Level | $57.27 | $85.18 |
| Resistance Level | $67.44 | $101.65 |
| Average True Range (ATR) | 1.35 | 2.31 |
| MACD | -0.14 | -0.22 |
| Stochastic Oscillator | 55.86 | 68.62 |
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.